UBS Group upgraded shares of Veritone (NASDAQ:VERI – Free Report) from a sell rating to a neutral rating in a report released on Wednesday, MarketBeat Ratings reports. The brokerage currently has $3.50 price objective on the stock.
Veritone Stock Performance
VERI stock opened at $3.26 on Wednesday. The stock’s 50 day simple moving average is $3.58 and its 200 day simple moving average is $3.19. The stock has a market capitalization of $124.14 million, a PE ratio of -1.51 and a beta of 3.33. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 9.02. Veritone has a 12-month low of $1.48 and a 12-month high of $7.76.
Veritone (NASDAQ:VERI – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.24) earnings per share for the quarter. The firm had revenue of $30.99 million for the quarter. Veritone had a negative net margin of 42.56% and a negative return on equity of 222.47%.
Hedge Funds Weigh In On Veritone
Veritone Company Profile
Veritone, Inc, together with its subsidiaries, engages in the provision of artificial intelligence (AI) computing solutions and services in the United States, the United Kingdom, France, Australia, Israel, and India. It develops and operates aiWARE platform, an AI operating system, that uses machine learning algorithms or AI models designed to mimic human cognitive functions, such as perception, prediction, and problem solving and optimization, as well as enables users to transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights.
Featured Stories
- Five stocks we like better than Veritone
- 3 Healthcare Dividend Stocks to Buy
- Battle of the Retailers: Who Comes Out on Top?
- What Investors Need to Know to Beat the Market
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Find and Profitably Trade Stocks at 52-Week Lows
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Veritone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veritone and related companies with MarketBeat.com's FREE daily email newsletter.